Intuitive Surgical, Inc. (NASDAQ:ISRG) shares rose nearly 9% on Wednesday after the company reported its Q3 results, with EPS of $1.19 coming in better than the Street estimate of $1.12. Revenue was $1.56 billion, compared to the Street estimate of $1.51 billion.
Among the key positives, Oppenheimer analysts mentioned the 2022 procedure guidance raise, and healthly Q3 as OUS procedure growth resilient (up 24%). Key concerns were (1) bottom-line miss, (2) revenues/procedures down, (3) 2022 adjusted gross margin guidance midpoint formally lowered, (4) hospital Capex weakening, and (5) procedure and utilization growth driven by easy comp.